Regulation of the Mutually Exclusive Exons 8a and 8 in the CaV1.2 Calcium Channel Transcript by Polypyrimidine Tract-binding Protein

CaV1.2 calcium channels play roles in diverse cellular processes such as gene regulation, muscle contraction, and membrane excitation and are diversified in their activity through extensive alternative splicing of the CaV1.2 mRNA. The mutually exclusive exons 8a and 8 encode alternate forms of transmembrane segment 6 (IS6) in channel domain 1. The human genetic disorder Timothy syndrome is caused by mutations in either of these two CaV1.2 exons, resulting in disrupted Ca2+ homeostasis and severe pleiotropic disease phenotypes. The tissue-specific pattern of exon 8/8a splicing leads to differences in symptoms between patients with exon 8 or 8a mutations. Elucidating the mechanisms controlling the exon 8/8a splicing choice will be important in understanding the spectrum of defects associated with the disease. We found that the polypyrimidine tract-binding protein (PTB) mediates a switch from exon 8 to 8a splicing. PTB and its neuronal homolog, nPTB, are widely studied splicing regulators controlling large sets of alternative exons. During neuronal development, PTB expression is down-regulated with a concurrent increase in nPTB expression. Exon 8a is largely repressed in embryonic mouse brain but is progressively induced during neuronal differentiation as PTB is depleted. This splicing repression is mediated by the direct binding of PTB to sequence elements upstream of exon 8a. The nPTB protein is a weaker repressor of exon 8a, resulting in a shift in exon choice when nPTB replaces PTB in cells. These results provide mechanistic understanding of how these two exons, important for human disease, are controlled.

[1]  R. Kole,et al.  RNA repair restores hemoglobin expression in IVS2–654 thalassemic mice , 2009, Proceedings of the National Academy of Sciences.

[2]  D. Black,et al.  Developmental Control of CaV1.2 L-Type Calcium Channel Splicing by Fox Proteins , 2009, Molecular and Cellular Biology.

[3]  R. Breathnach,et al.  Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon , 1995, Molecular and cellular biology.

[4]  H. Reuter,et al.  Ca2+ channel sensitivity towards the blocker isradipine is affected by alternative splicing of the human α1C subunit gene , 1998, FEBS letters.

[5]  D. Lipscombe,et al.  Functional diversity in neuronal voltage-gated calcium channels by alternative splicing of Cavα1 , 2002, Molecular Neurobiology.

[6]  Brenda F Baker,et al.  Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon , 2007, PLoS biology.

[7]  T. Soong,et al.  CaV1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency , 2010, Pflügers Archiv - European Journal of Physiology.

[8]  Lili Wan,et al.  RNA and Disease , 2009, Cell.

[9]  Frank B Sachse,et al.  Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. McDonough Calcium Channel Pharmacology , 2012, Springer US.

[11]  P. Grabowski,et al.  Mutations in RRM4 uncouple the splicing repression and RNA-binding activities of polypyrimidine tract binding protein. , 2002, RNA.

[12]  R. Tsien,et al.  The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels , 2008, Proceedings of the National Academy of Sciences.

[13]  S. Priori,et al.  CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism , 2004, Cell.

[14]  T. Soong,et al.  Signature combinatorial splicing profiles of rat cardiac- and smooth-muscle Cav1.2 channels with distinct biophysical properties. , 2007, Cell calcium.

[15]  J. Striessnig Pharmacology, Structure and Function of Cardiac L-Type Ca2+ Channels , 1999, Cellular Physiology and Biochemistry.

[16]  Christopher W. J. Smith Alternative Splicing— When Two’s a Crowd , 2005, Cell.

[17]  Christopher W. J. Smith,et al.  Novel modes of splicing repression by PTB. , 2006, Trends in biochemical sciences.

[18]  N. Klugbauer,et al.  Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels. , 1997, Circulation research.

[19]  D. Black,et al.  Combinatorial control of a neuron-specific exon. , 1999, RNA.

[20]  D. T. Yue,et al.  Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles. , 2005, Cardiovascular research.

[21]  T. Werge,et al.  CACNA1C (rs1006737) is associated with schizophrenia , 2010, Molecular Psychiatry.

[22]  Mark E. Anderson,et al.  Proarrhythmic Defects in Timothy Syndrome Require Calmodulin Kinase II , 2008, Circulation.

[23]  William A Catterall,et al.  Voltage-Gated Calcium Channels , 2011 .

[24]  J. Lueck,et al.  Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. , 2007, The Journal of clinical investigation.

[25]  Peer Bork,et al.  Common exon duplication in animals and its role in alternative splicing. , 2002, Human molecular genetics.

[26]  W. Catterall Structure and regulation of voltage-gated Ca2+ channels. , 2000, Annual review of cell and developmental biology.

[27]  N. Soldatov Genomic structure of human L-type Ca2+ channel. , 1994, Genomics.

[28]  R. Dolmetsch,et al.  Signaling to the Nucleus by an L-type Calcium Channel-Calmodulin Complex Through the MAP Kinase Pathway , 2001, Science.

[29]  W. Fairbrother,et al.  Repressing the neuron within. , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[30]  T. Soong,et al.  Alternative splicing of voltage-gated calcium channels: from molecular biology to disease , 2009, Pflügers Archiv - European Journal of Physiology.

[31]  Douglas L Black,et al.  Exon repression by polypyrimidine tract binding protein. , 2005, RNA.

[32]  Robert T. Schultz,et al.  Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.

[33]  Guey-Shin Wang,et al.  Splicing in disease: disruption of the splicing code and the decoding machinery , 2007, Nature Reviews Genetics.

[34]  Christopher W. J. Smith,et al.  Mutually exclusive splicing of α-tropomyosin exons enforced by an unusual lariat branch point location: Implications for constitutive splicing , 1989, Cell.

[35]  G. van Ommen,et al.  Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  Manuel A. R. Ferreira,et al.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.

[37]  D. Black,et al.  Cooperative Assembly of an hnRNP Complex Induced by a Tissue-Specific Homolog of Polypyrimidine Tract Binding Protein , 2000, Molecular and Cellular Biology.

[38]  L. Gangwani,et al.  A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy , 2009, RNA biology.

[39]  D. Black Activation of c-src neuron-specific splicing by an unusual RNA element in vivo and in vitro , 1992, Cell.

[40]  D. Lipscombe Neuronal proteins custom designed by alternative splicing , 2005, Current Opinion in Neurobiology.

[41]  D L Black,et al.  A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon , 1997, Molecular and cellular biology.

[42]  Christopher J. Lee,et al.  Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss , 2003, Nature Genetics.

[43]  Tohru Suzuki,et al.  The Nonsense-mediated Decay Pathway and Mutually Exclusive Expression of Alternatively Spliced FGFR2IIIb and -IIIc mRNAs* , 2001, The Journal of Biological Chemistry.

[44]  David Haussler,et al.  Unusual Intron Conservation near Tissue-Regulated Exons Found by Splicing Microarrays , 2005, PLoS Comput. Biol..

[45]  T. Maniatis,et al.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. , 2007, Molecular cell.

[46]  K. Deisseroth,et al.  Calmodulin supports both inactivation and facilitation of L-type calcium channels , 1999, Nature.

[47]  R. Sorek,et al.  Intronic sequences flanking alternatively spliced exons are conserved between human and mouse. , 2003, Genome research.

[48]  D. Abernethy,et al.  Structure-functional diversity of human L-type Ca2+ channel: perspectives for new pharmacological targets. , 2002, The Journal of pharmacology and experimental therapeutics.

[49]  Johan T den Dunnen,et al.  Local dystrophin restoration with antisense oligonucleotide PRO051. , 2007, The New England journal of medicine.

[50]  D. Black,et al.  Structure of PTB Bound to RNA: Specific Binding and Implications for Splicing Regulation , 2005, Science.

[51]  L. Maquat,et al.  Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. , 2005, Current opinion in cell biology.

[52]  Douglas L Black,et al.  A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. , 2007, Genes & development.

[53]  P. Iversen,et al.  Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[54]  D. Black,et al.  MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. , 2007, Genes & development.

[55]  Russ P. Carstens,et al.  An Intronic Splicing Silencer Causes Skipping of the IIIb Exon of Fibroblast Growth Factor Receptor 2 through Involvement of Polypyrimidine Tract Binding Protein , 2000, Molecular and Cellular Biology.

[56]  S. Stamm,et al.  Alternative splicing and disease. , 2009, Biochimica et biophysica acta.

[57]  C. Klee,et al.  Calcium as a cellular regulator , 1999 .

[58]  A. Koschak,et al.  α1D (Cav1.3) Subunits Can Form L-type Ca2+ Channels Activating at Negative Voltages* , 2001, The Journal of Biological Chemistry.

[59]  A. J. Castiglioni,et al.  Alternative Splicing in Voltage Gated Calcium Channels , 2004 .

[60]  F. Lehmann-Horn,et al.  The impact of splice isoforms on voltage‐gated calcium channel α1 subunits , 2004, The Journal of physiology.

[61]  C. Smith,et al.  Crossregulation and Functional Redundancy between the Splicing Regulator PTB and Its Paralogs nPTB and ROD1 , 2007, Molecular cell.

[62]  Douglas L. Black,et al.  Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex. , 2005, Molecular cell.

[63]  B. Rubin,et al.  The Molecular Basis of Familial Dysautonomia: Overview, New Discoveries and Implications for Directed Therapies , 2007, NeuroMolecular Medicine.

[64]  C. D. de Winter,et al.  Therapeutic Modulation of DMD Splicing by Blocking Exonic Splicing Enhancer Sites with Antisense Oligonucleotides , 2006, Annals of the New York Academy of Sciences.

[65]  N. Soldatov Molecular diversity of L-type Ca2+ channel transcripts in human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[66]  G. Lutz,et al.  Oligonucleotide-Mediated Survival of Motor Neuron Protein Expression in CNS Improves Phenotype in a Mouse Model of Spinal Muscular Atrophy , 2009, The Journal of Neuroscience.

[67]  Adrian R Krainer,et al.  Splicing therapeutics in SMN2 and APOB. , 2009, Current opinion in molecular therapeutics.

[68]  Douglas L. Black,et al.  Neuronal regulation of alternative pre-mRNA splicing , 2007, Nature Reviews Neuroscience.

[69]  E. Blaskova,et al.  Alternative splicing of Cav1.2 channel exons in smooth muscle cells of resistance-size arteries generates currents with unique electrophysiological properties. , 2009, American journal of physiology. Heart and circulatory physiology.

[70]  Dejie Yu,et al.  Transcript Scanning Reveals Novel and Extensive Splice Variations in Human L-type Voltage-gated Calcium Channel, Cav1.2 α1 Subunit* , 2004, Journal of Biological Chemistry.

[71]  T. Soong,et al.  Differential splicing patterns of L-type calcium channel Cav1.2 subunit in hearts of Spontaneously Hypertensive Rats and Wistar Kyoto Rats. , 2008, Biochimica et biophysica acta.

[72]  Tomaso Poggio,et al.  Identification and analysis of alternative splicing events conserved in human and mouse. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[73]  M. Wood,et al.  RNA-targeted splice-correction therapy for neuromuscular disease. , 2010, Brain : a journal of neurology.